Vildagliptin

Vildagliptin

Catalog Number:
P004517011LIF
Mfr. No.:
PEPTIDE-PI-230
Price:
$183
  • Size:
    10mg
    Quantity:
    Add to Cart:
      • Overview
        • Dipeptidyl peptidase IV (DPP-IV) inhibitor.
          Vildagliptin, also known as LAF237, is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin inhibits the inactivation of glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) by DPP-IV, allowing GLP-1 and GIP to potentiate the secretion of insulin and suppress glucagon release in the pancreas. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity in type 2 diabetes.

          Please contact us for availability.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Small Molecules
          Alternative Name
          LAF237
          Molecular Formula
          C17H25N3O2
          Molecular Weight
          303.4
          Appearance
          White solid
          Purity
          98% by TLC
          Solubility
          Soluble in water
          Other Properties
          Sequence: 1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile,1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile
          Storage
          Store desiccated, frozen and in the dark

          * Please note: this product can only be supplied to registered research and development facilities, and may be used for in vitro research use only, not for administration to humans or animals.

    We Also Recommend

    WP 1130

    $257

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.